Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2021

View Archived Issues

SSTR5 splice variant sst5TMD4 for diagnosis and prognosis of high-grade gliomas

Fecal microbiota transplantation used to create autism model in rat offspring

Bispecific antibody may allow safer targeting of the IL-2 signaling pathway

Corbus licenses integrin-targeting MAbs, CRB-601 and CRB-602

China's NMPA accepts IND application for CT-120, a dual-antigen specific CAR-T therapy

Oyster Point expands its pipeline and announces promising preclinical data

Hoth Therapeutics reports preclinical data for novel HT-KIT candidate

Monopar and the National University of Singapore collaborate on development of MNPR-202

Multi-characteristic opsin gene therapy restores clinically meaningful vision in patients with RP

Algernon launches new clinical research program for ifenprodil in pancreatic cancer

First patient dosed in phase I/II study of PhageBank in urinary tract infections

Histogen provides development and pipeline updates

Karolinska announces that Dilafor successfully concluded its phase IIb study of tafoxiparin

Betta Pharmaceuticals patents PI3K inhibitors

LG Chem discloses new melanocortin MC4 receptor agonists

Dermira synthesizes new MRGPRX2 antagonists

Hangzhou Hertz Pharmaceutical divulges PD-1/PD-L1 interaction inhibitors

University of California identifies ROR2-targeting antibodies for cancer

BI-655064 does not meet CRR primary endpoint in lupus nephritis phase II trial

Evaxion reports preclinical proof-of-concept data for its AI-powered RAVEN vaccine platform

Novartis initiates recruitment in phase I study of INE-963

PINK1 and Parkin stabilize mutations in mitochondrial DNA

INO-4700 MERS-CoV vaccine candidate enters phase II studies

Gilead Sciences initiates phase I study of KITE-222 autologous CAR-T cell therapy

KZR-616 is safe and well tolerated in patients with active SLE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...